Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

著者: Sara A. Hurvitz, Fabrice André, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia Dreosti, Howard A. Burris, Masakazu Toi, Marc Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Pacaud, Tetiana Taran, Dennis J. Slamon - The Lancet 2015 被引用: 306